93. 原発性胆汁性胆管炎 Primary biliary cholangitis Clinical trials / Disease details
臨床試験数 : 298 / 薬物数 : 252 - (DrugBank : 59) / 標的遺伝子数 : 35 - 標的パスウェイ数 : 115
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00805805 (ClinicalTrials.gov) | April 2006 | 8/12/2008 | Study Comparing Tetrathiomolybdate vs Standard Treatment in Primary Biliary Cirrhosis | Phase III Trial of Tetrathiomolybdate (TM) in Primary Biliary Cirrhosis | Primary Biliary Cirrhosis | Drug: Tetrathiomolybdate;Other: Placebo | George Brewer | FDA Office of Orphan Products Development | Completed | 18 Years | N/A | All | 29 | Phase 3 | United States |